BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $464,340,000 | +3.7% | 3,071,644 | -0.0% | 0.76% | +8.4% |
| Q2 2022 | $447,598,000 | +23.8% | 3,071,839 | +0.8% | 0.70% | +42.2% |
| Q1 2022 | $361,410,000 | -14.0% | 3,048,068 | -0.1% | 0.49% | -11.3% |
| Q4 2021 | $420,319,000 | +1.1% | 3,049,995 | +1.9% | 0.56% | -8.9% |
| Q3 2021 | $415,944,000 | +66.7% | 2,994,345 | +16.5% | 0.61% | +63.5% |
| Q2 2021 | $249,499,000 | +42.3% | 2,570,041 | +0.2% | 0.37% | +29.1% |
| Q1 2021 | $175,306,000 | -19.6% | 2,564,822 | +0.9% | 0.29% | -25.7% |
| Q4 2020 | $217,916,000 | +32.6% | 2,542,474 | +0.6% | 0.39% | +15.1% |
| Q3 2020 | $164,348,000 | -9.8% | 2,528,043 | +1.5% | 0.34% | -19.3% |
| Q2 2020 | $182,123,000 | +88.5% | 2,491,086 | -12.2% | 0.42% | +56.9% |
| Q1 2020 | $96,596,000 | -37.5% | 2,838,546 | +0.1% | 0.27% | -17.1% |
| Q4 2019 | $154,449,000 | +30.5% | 2,837,046 | 0.0% | 0.32% | +6.6% |
| Q3 2019 | $118,362,000 | -4.8% | 2,837,046 | -0.1% | 0.30% | -5.9% |
| Q2 2019 | $124,299,000 | -14.6% | 2,838,538 | +0.4% | 0.32% | -21.9% |
| Q1 2019 | $145,507,000 | +44.7% | 2,827,038 | +4.0% | 0.41% | +26.5% |
| Q4 2018 | $100,569,000 | +545.2% | 2,719,538 | +555.2% | 0.32% | +622.2% |
| Q3 2018 | $15,587,000 | -5.0% | 415,100 | 0.0% | 0.04% | -10.0% |
| Q2 2018 | $16,405,000 | +53.4% | 415,100 | 0.0% | 0.05% | +47.1% |
| Q1 2018 | $10,693,000 | -4.6% | 415,100 | -0.0% | 0.03% | -5.6% |
| Q4 2017 | $11,206,000 | -27.8% | 415,300 | 0.0% | 0.04% | -33.3% |
| Q3 2017 | $15,525,000 | +49.6% | 415,300 | +0.0% | 0.05% | +42.1% |
| Q2 2017 | $10,381,000 | – | 415,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |